 |
a strain of modified live probiotic bacterium Escherichia coli (E.coli) Nissle 1917 that has been modified to treat phenylketonuria by consuming phenylalanine within the gastrointestinal tract |
|---|---|
| Trade Name | |
| Orphan Indication | Phenylketonuria |
| USA Market Approval | USA |
| USA Designation Date | 2017-10-18 00:00:00 |
| Sponsor | Synlogic, Inc.;200 Sidney Street, Suite 320;Cambridge, Massachusetts, 02139 |
